United States Cytotoxic Drug Market by Manufacturers, States, Type and Application, Forecast to 2022

Publisher Name :
Date: 15-Jan-2018
No. of pages: 116

Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic' and ‘cytotoxic' are often used interchangeably.

Scope of the Report:

This report focuses on the Cytotoxic Drug in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers

  • Roche

  • Eli Lilly

  • Celgene

  • Sanofi

  • eisai

  • Sumitomo Dainippon Pharma

  • Merck

  • Seattle Genetics

  • Takeda

  • Haosoh Pharma

  • Novartis

  • AstraZeneca

  • Jazz Pharma

  • Spectrum Pharma

Market Segment by States, covering

  • California

  • Texas

  • New York

  • Florida

  • Illinois

Market Segment by Type, covers

  • Injection

  • Solid Oral Dose Forms

  • Others

Market Segment by Applications, can be divided into

  • Breast Cancer

  • Blood Cancer

  • Prostate Cancer

  • Respiratory/Lung Cancer

  • Other

There are 17 Chapters to deeply display the United States Cytotoxic Drug market.

Chapter 1, to describe Cytotoxic Drug Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Cytotoxic Drug, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Cytotoxic Drug, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Cytotoxic Drug market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Cytotoxic Drug Research Findings and Conclusion, Appendix, methodology and data source.

United States Cytotoxic Drug Market by Manufacturers, States, Type and Application, Forecast to 2022

Table of Contents

1 Market Overview
1.1 Cytotoxic Drug Introduction
1.2 Market Analysis by Type
1.2.1 Injection
1.2.2 Solid Oral Dose Forms
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Breast Cancer
1.3.2 Blood Cancer
1.3.3 Prostate Cancer
1.3.4 Respiratory/Lung Cancer
1.3.5 Other
1.4 Market Analysis by States
1.4.1 California Status and Prospect (2012-2022)
1.4.2 Texas Status and Prospect (2012-2022)
1.4.3 New York Status and Prospect (2012-2022)
1.4.4 Florida Status and Prospect (2012-2022)
1.4.5 Illinois Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force

2 Manufacturers Profiles
2.1 Roche
2.1.1 Profile
2.1.2 Cytotoxic Drug Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Roche Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Roche News
2.2 Eli Lilly
2.2.1 Profile
2.2.2 Cytotoxic Drug Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Eli Lilly Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Eli Lilly News
2.3 Celgene
2.3.1 Profile
2.3.2 Cytotoxic Drug Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Celgene Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Celgene News
2.4 Sanofi
2.4.1 Profile
2.4.2 Cytotoxic Drug Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Sanofi Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Sanofi News
2.5 eisai
2.5.1 Profile
2.5.2 Cytotoxic Drug Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 eisai Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 eisai News
2.6 Sumitomo Dainippon Pharma
2.6.1 Profile
2.6.2 Cytotoxic Drug Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Sumitomo Dainippon Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Sumitomo Dainippon Pharma News
2.7 Merck
2.7.1 Profile
2.7.2 Cytotoxic Drug Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Merck Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Merck News
2.8 Seattle Genetics
2.8.1 Profile
2.8.2 Cytotoxic Drug Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Seattle Genetics Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 Seattle Genetics News
2.9 Takeda
2.9.1 Profile
2.9.2 Cytotoxic Drug Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Takeda Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Takeda News
2.10 Haosoh Pharma
2.10.1 Profile
2.10.2 Cytotoxic Drug Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Haosoh Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 Haosoh Pharma News
2.11 Novartis
2.11.1 Profile
2.11.2 Cytotoxic Drug Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Novartis Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11.4 Business Overview
2.11.5 Novartis News
2.12 AstraZeneca
2.12.1 Profile
2.12.2 Cytotoxic Drug Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 AstraZeneca Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12.4 Business Overview
2.12.5 AstraZeneca News
2.13 Jazz Pharma
2.13.1 Profile
2.13.2 Cytotoxic Drug Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Jazz Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13.4 Business Overview
2.13.5 Jazz Pharma News
2.14 Spectrum Pharma
2.14.1 Profile
2.14.2 Cytotoxic Drug Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Spectrum Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14.4 Business Overview
2.14.5 Spectrum Pharma News

3 United States Cytotoxic Drug Market Competition, by Manufacturer
3.1 United States Cytotoxic Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 United States Cytotoxic Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 United States Cytotoxic Drug Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Cytotoxic Drug Manufacturer Market Share
3.4.2 Top 5 Cytotoxic Drug Manufacturer Market Share
3.5 Market Competition Trend

4 United States Cytotoxic Drug Market Analysis by States
4.1 United States Cytotoxic Drug Sales Market Share by States
4.2 United States Cytotoxic Drug Sales by States (2012-2017)
4.3 United States Cytotoxic Drug Revenue (Value) by States (2012-2017)

5 United States Market Segmentation Cytotoxic Drug by Type
5.1 United States Cytotoxic Drug Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 United States Cytotoxic Drug Sales and Market Share by Type (2012-2017)
5.1.2 United States Cytotoxic Drug Revenue and Market Share by Type (2012-2017)
5.2 Injection Sales Growth and Price
5.2.1 United States Injection Sales Growth (2012-2017)
5.2.2 United States Injection Price (2012-2017)
5.3 Solid Oral Dose Forms Sales Growth and Price
5.3.1 United States Solid Oral Dose Forms Sales Growth (2012-2017)
5.3.2 United States Solid Oral Dose Forms Price (2012-2017)
5.4 Others Sales Growth and Price
5.4.1 United States Others Sales Growth (2012-2017)
5.4.2 United States Others Price (2012-2017)

6 United States Market Segmentation Cytotoxic Drug by Application
6.1 United States Cytotoxic Drug Sales Market Share by Application (2012-2017)
6.2 Breast Cancer Sales Growth (2012-2017)
6.3 Blood Cancer Sales Growth (2012-2017)
6.4 Prostate Cancer Sales Growth (2012-2017)
6.5 Respiratory/Lung Cancer Sales Growth (2012-2017)
6.6 Other Sales Growth (2012-2017)

7 California Cytotoxic Drug Sales, Revenue, by Type, Application and Manufacturers
7.1 California Cytotoxic Drug Revenue, Sales and Growth Rate (2012-2017)
7.2 California Cytotoxic Drug Sales and Market Share by Type
7.3 California Cytotoxic Drug Sales by Application (2012-2017)

8 New York Cytotoxic Drug Sales, Revenue, by Type, Application and Manufacturers
8.1 New York Cytotoxic Drug Revenue, Sales and Growth Rate (2012-2017)
8.2 New York Cytotoxic Drug Sales and Market Share by Type
8.3 New York Cytotoxic Drug Sales by Application (2012-2017)

9 Texas Cytotoxic Drug Sales, Revenue, by Type, Application and Manufacturers
9.1 Texas Cytotoxic Drug Revenue, Sales and Growth Rate (2012-2017)
9.2 Texas Cytotoxic Drug Sales and Market Share by Type
9.3 Texas Cytotoxic Drug Sales by Application (2012-2017)

10 Florida Cytotoxic Drug Sales, Revenue, by Type, Application and Manufacturers
10.1 Florida Cytotoxic Drug Revenue, Sales and Growth Rate (2012-2017)
10.2 Florida Cytotoxic Drug Sales and Market Share by Type
10.3 Florida Cytotoxic Drug Sales by Application (2012-2017)

11 Illinois Cytotoxic Drug Sales, Revenue, by Type, Application and Manufacturers
11.1 Illinois Cytotoxic Drug Revenue, Sales and Growth Rate (2012-2017)
11.2 Illinois Cytotoxic Drug Sales and Market Share by Type
11.3 Illinois Cytotoxic Drug Sales by Application (2012-2017)

12 Cytotoxic Drug Market Forecast (2017-2022)
12.1 United States Cytotoxic Drug Sales, Revenue and Growth Rate (2017-2022)
12.2 Cytotoxic Drug Market Forecast by States (2017-2022)
12.3 Cytotoxic Drug Market Forecast by Type (2017-2022)
12.4 Cytotoxic Drug Market Forecast by Application (2017-2022)

13 Cytotoxic Drug Manufacturing Cost Analysis
13.1 Cytotoxic Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Price Trend of Key Raw Materials
13.1.3 Key Suppliers of Raw Materials
13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.2.1 Raw Materials
13.2.2 Labor Cost
13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Cytotoxic Drug

14 Industrial Chain, Sourcing Strategy and Downstream Buyers
14.1 Cytotoxic Drug Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Cytotoxic Drug Major Manufacturers in 2016
14.4 Downstream Buyers

15 Sales Channel, Distributors, Traders and Dealers
15.1 Sales Channel
15.1.1 Direct Marketing
15.1.2 Indirect Marketing
15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology
17.2 Analyst Introduction
17.3 Data Source

List of Tables and Figures

Figure Cytotoxic Drug Picture
Table Product Specifications of Cytotoxic Drug
Figure United States Sales Market Share of Cytotoxic Drug by Types in 2016
Table Types of Cytotoxic Drug
Figure Injection Picture
Table Major Manufacturers of Injection
Figure Solid Oral Dose Forms Picture
Table Major Manufacturers of Solid Oral Dose Forms
Figure Others Picture
Table Major Manufacturers of Others
Table United States Cytotoxic Drug Sales Market Share by Applications in 2016
Table Applications of Cytotoxic Drug
Figure Breast Cancer Picture
Figure Blood Cancer Picture
Figure Prostate Cancer Picture
Figure Respiratory/Lung Cancer Picture
Figure Other Picture
Figure California Cytotoxic Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Texas Cytotoxic Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New York Cytotoxic Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Florida Cytotoxic Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Illinois Cytotoxic Drug Revenue (Million USD) and Growth Rate (2012-2022)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Cytotoxic Drug Type and Applications
Table Roche Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Cytotoxic Drug Type and Applications
Table Eli Lilly Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Cytotoxic Drug Type and Applications
Table Celgene Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Cytotoxic Drug Type and Applications
Table Sanofi Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table eisai Basic Information, Manufacturing Base and Competitors
Table eisai Cytotoxic Drug Type and Applications
Table eisai Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sumitomo Dainippon Pharma Basic Information, Manufacturing Base and Competitors
Table Sumitomo Dainippon Pharma Cytotoxic Drug Type and Applications
Table Sumitomo Dainippon Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Cytotoxic Drug Type and Applications
Table Merck Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Seattle Genetics Basic Information, Manufacturing Base and Competitors
Table Seattle Genetics Cytotoxic Drug Type and Applications
Table Seattle Genetics Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Cytotoxic Drug Type and Applications
Table Takeda Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Haosoh Pharma Basic Information, Manufacturing Base and Competitors
Table Haosoh Pharma Cytotoxic Drug Type and Applications
Table Haosoh Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Cytotoxic Drug Type and Applications
Table Novartis Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Cytotoxic Drug Type and Applications
Table AstraZeneca Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Jazz Pharma Basic Information, Manufacturing Base and Competitors
Table Jazz Pharma Cytotoxic Drug Type and Applications
Table Jazz Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Spectrum Pharma Basic Information, Manufacturing Base and Competitors
Table Spectrum Pharma Cytotoxic Drug Type and Applications
Table Spectrum Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table United States Cytotoxic Drug Sales by Manufacturer (2016-2017)
Figure United States Cytotoxic Drug Sales Market Share by Manufacturer in 2016
Figure United States Cytotoxic Drug Sales Market Share by Manufacturer in 2017
Table United States Cytotoxic Drug Revenue by Manufacturer (2016-2017)
Figure United States Cytotoxic Drug Revenue Market Share by Manufacturer in 2015
Figure United States Cytotoxic Drug Revenue Market Share by Manufacturer in 2016
Table United States Cytotoxic Drug Price by Manufacturers (2016-2017)
Figure Top 3 Cytotoxic Drug Manufacturer Market Share in 2016
Figure Top 3 Cytotoxic Drug Manufacturer Market Share in 2017
Figure Top 5 Cytotoxic Drug Manufacturer Market Share in 2016
Figure Top 5 Cytotoxic Drug Manufacturer Market Share in 2017
Figure United States Cytotoxic Drug Sales and Growth (2012-2017)
Table United States Cytotoxic Drug Sales by States (2012-2017)
Table United States Cytotoxic Drug Sales Market Share by States (2012-2017)
Figure United States 2012 Cytotoxic Drug Sales Market Share by States
Figure United States 2016 Cytotoxic Drug Sales Market Share by States
Figure United States Cytotoxic Drug Revenue and Growth (2012-2017)
Table United States Cytotoxic Drug Revenue by States (2012-2017)
Table United States Cytotoxic Drug Revenue Market Share by States (2012-2017)
Table United States 2012 Cytotoxic Drug Revenue Market Share by States
Table United States 2016 Cytotoxic Drug Revenue Market Share by States
Table United States Cytotoxic Drug Sales by Type (2012-2017)
Table United States Cytotoxic Drug Sales Share by Type (2012-2017)
Table United States Cytotoxic Drug Revenue by Type (2012-2017)
Table United States Cytotoxic Drug Revenue Share by Type (2012-2017)
Figure United States Injection Sales Growth (2012-2017)
Figure United States Injection Price (2012-2017)
Figure United States Solid Oral Dose Forms Sales Growth (2012-2017)
Figure United States Solid Oral Dose Forms Price (2012-2017)
Figure United States Others Sales Growth (2012-2017)
Figure United States Others Price (2012-2017)
Table United States Cytotoxic Drug Sales by Application (2012-2017)
Table United States Cytotoxic Drug Sales Share by Application (2012-2017)
Figure United States Breast Cancer Sales Growth (2012-2017)
Figure United States Blood Cancer Sales Growth (2012-2017)
Figure United States Prostate Cancer Sales Growth (2012-2017)
Figure United States Respiratory/Lung Cancer Sales Growth (2012-2017)
Figure United States Other Sales Growth (2012-2017)
Figure California Cytotoxic Drug Revenue and Growth (2012-2017)
Figure California Cytotoxic Drug Sales and Growth (2012-2017)
Table California Cytotoxic Drug Sales by Type (2012-2017)
Table California Cytotoxic Drug Sales Market Share by Type (2012-2017)
Table California Cytotoxic Drug Sales by Application (2012-2017)
Table California Cytotoxic Drug Sales Market Share by Application (2012-2017)
Figure New York Cytotoxic Drug Revenue and Growth (2012-2017)
Figure New York Cytotoxic Drug Sales and Growth (2012-2017)
Table New York Cytotoxic Drug Sales by Type (2012-2017)
Table New York Cytotoxic Drug Sales Market Share by Type (2012-2017)
Table New York Cytotoxic Drug Sales by Application (2012-2017)
Table New York Cytotoxic Drug Sales Market Share by Application (2012-2017)
Figure Texas Cytotoxic Drug Revenue and Growth (2012-2017)
Figure Texas Cytotoxic Drug Sales and Growth (2012-2017)
Table Texas Cytotoxic Drug Sales by Type (2012-2017)
Table Texas Cytotoxic Drug Sales Market Share by Type (2012-2017)
Table Texas Cytotoxic Drug Sales by Application (2012-2017)
Table Texas Cytotoxic Drug Sales Market Share by Application (2012-2017)
Figure Florida Cytotoxic Drug Revenue and Growth (2012-2017)
Figure Florida Cytotoxic Drug Sales and Growth (2012-2017)
Table Florida Cytotoxic Drug Sales by Type (2012-2017)
Table Florida Cytotoxic Drug Sales Market Share by Type (2012-2017)
Table Florida Cytotoxic Drug Sales by Application (2012-2017)
Table Florida Cytotoxic Drug Sales Market Share by Application (2012-2017)
Figure Illinois Cytotoxic Drug Revenue and Growth (2012-2017)
Figure Illinois Cytotoxic Drug Sales and Growth (2012-2017)
Table Illinois Cytotoxic Drug Sales by Type (2012-2017)
Table Illinois Cytotoxic Drug Sales Market Share by Type (2012-2017)
Table Illinois Cytotoxic Drug Sales by Application (2012-2017)
Table Illinois Cytotoxic Drug Sales Market Share by Application (2012-2017)
Figure United States Cytotoxic Drug Sales, Revenue and Growth Rate (2017-2022)
Table United States Cytotoxic Drug Sales Forecast by States (2017-2022)
Table United States Cytotoxic Drug Market Share Forecast by States (2017-2022)
Table United States Cytotoxic Drug Sales Forecast by Type (2017-2022)
Table United States Cytotoxic Drug Market Share Forecast by Type (2017-2022)
Table United States Cytotoxic Drug Sales Forecast by Application (2017-2022)
Table United States Cytotoxic Drug Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cytotoxic Drug
Figure Manufacturing Process Analysis of Cytotoxic Drug
Figure Cytotoxic Drug Industrial Chain Analysis
Table Raw Materials Sources of Cytotoxic Drug Major Manufacturers in 2016
Table Major Buyers of Cytotoxic Drug
Table Distributors/Traders/ Dealers List
  • Global Erlotinib Hydrochloride Market Insights, Forecast to 2025
    Published: 15-Aug-2018        Price: US 3900 Onwards        Pages: 99
    This report studies the global market size of Erlotinib Hydrochloride in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Erlotinib Hydrochloride in these regions. This research report categorizes the global Erlotinib Hydrochloride market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, mark......
  • Global and India Cancer Treatment Drugs Market Research by Company, Type & Application 2013-2025
    Published: 15-Aug-2018        Price: US 2000 Onwards        Pages: 120
    Summary Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Market Segment as follows: By Type - Chemotherapy - Targeted Therapy - Immunotherapy (Biologic Therapy) - Hormonal Therapy - Others By Application - Blood Cancer - Breast Cancer - ......
  • Global Capecitabine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Aug-2018        Price: US 3480 Onwards        Pages: 134
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Scope of the Report: This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Capecitabine Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 135
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Scope of the Report: This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This......
  • Global and India Capecitabine Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 99
    Summary Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Market Segment as follows: By Type - 500 mg - 150 mg By Application - Breast Cancer - Colorectal cancer - Stomach Cancer ......
  • Global and India Mitomycin C Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 102
    Summary Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.). Market Segment as follows: By Type - 2 Mg - 10 Mg - 40 Mg - Others By Application - Cancer Trea......
  • Global and India Erlotinib Hydrochloride Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 122
    Summary Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epidermal growth factor receptor (EGFR), and it works by interfering with the growth of cancer cells ......
  • 2018-2023 Global Cancer Treatment Drugs Consumption Market Report
    Published: 10-Aug-2018        Price: US 4660 Onwards        Pages: 179
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Cancer Treatment Drugs market for 2018-2023. Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. The classification of cancer treatment drugs includes chemotherapy, targeted th......
  • Global Hydroxycarbamide Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 10-Aug-2018        Price: US 3480 Onwards        Pages: 137
    Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth. Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs